Elanco Animal Health (ELAN)

Elanco Animal Health Incorporated is a healthcare company focused on animal health products for pets and farm animals. The company develops, manufactures, and markets a range of offerings worldwide, including parasiticides, vaccines, and therapeutics for companion animals under brands such as Seresto, K-9 Advantage, Advantix, Advocate, Credelio Family, Interceptor Plus, Drontal, Drontal Plus, and Galliprant. Its pet health portfolio also includes products used for pain, otitis, cardiovascular, dermatology, and osteoarthritis indications in dogs and cats. For farm animals, Elanco supplies products intended to support livestock health and productivity across cattle, swine, and poultry, including medicated feed additives, injectable antibiotics, vaccines, insecticides, and enzymes. The company sells through third-party distributors and independent retailers, as well as directly to farm animal producers and veterinarians. Founded in 1954, Elanco is headquartered in Indianapolis, Indiana, and its common stock is listed on the NYSE under the symbol ELAN.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.